Further examination of key findings of Policy Innovation Memorandum on safety of world drug, vaccine supply

NewsGuard 100/100 Score

In this post on her blog, "The Garrett Update" -- the last of a series of posts examining the safety of drugs and vaccines -- Laurie Garrett, senior fellow for global health at the Council on Foreign Relations (CFR), further details the key findings of the CFR's Policy Innovation Memorandum No. 21, a six-point policy recommendation for the G8/20 that she authored, titled "Ensuring the Safety and Integrity of the World's Drug, Vaccine, and Medicines Supply." She concludes, "The crisis is global, growing and massive. Unless international solutions are eagerly embraced, such as we and others have recommended, the very integrity of Medicine and Public Health will be undermined amid a steadily rising toll of illnesses and deaths ascribed to bad medicines" (May 2012).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Personalized anti-tumor vaccine enhances immunotherapy for liver cancer